Dr. Hong Ni 倪虹
Chief Physician
Department of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive interventional therapy for tumors and complications, including liver, lung, pancreatic, gastric, ovarian, cervical, and uterine cancers, as well as metastases, adenomyosis, and fibroids.
Dr. Ni holds a PhD in Oncology from Tianjin Medical University and completed a postdoctoral fellowship in minimally invasive therapy at the Medical University of South Carolina. Dr. Ni received clinical training at MD Anderson Cancer Center. As a Chief Physician, Dr. Ni treats various cancers and complications such as ascites and bowel obstruction, and has published multiple papers.
Name order: in Chinese the family name comes first (Ni Hong). Papers usually list the name as Hong Ni or Ni H.
Selected publications
7 papers on PubMed matched by name and affiliation; 2 as first or senior author since 2016. Most recent first- or senior-author papers:
- Oncotarget, 2017 (senior author): CT-guided (125)I brachytherapy for recurrent ovarian cancer. PubMed 28938680
- Onco Targets Ther, 2017 (senior author): CT-guided (125)I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy. PubMed 28860816
- Cancer Chemother Pharmacol, 2015 (senior author): Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients. PubMed 26542279
- Cancer Chemother Pharmacol, 2015 (senior author): Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer. PubMed 25428515
- Int J Gynecol Cancer, 2014 (senior author): Computed tomography-guided 125I seed interstitial implantation in the treatment of recurrent ovarian cancer. PubMed 25248113
- Zhonghua Yi Xue Za Zhi, 2011 (senior author): [Clinical study of cryoablation in the salvage treatment of stage III non-small cell lung cancer]. PubMed 22094040
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion